These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

557 related items for PubMed ID: 26446507

  • 1. Safety and effectiveness of dabigatran and warfarin in routine care of patients with atrial fibrillation.
    Seeger JD, Bykov K, Bartels DB, Huybrechts K, Zint K, Schneeweiss S.
    Thromb Haemost; 2015 Nov 25; 114(6):1277-89. PubMed ID: 26446507
    [Abstract] [Full Text] [Related]

  • 2. A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system.
    Villines TC, Schnee J, Fraeman K, Siu K, Reynolds MW, Collins J, Schwartzman E.
    Thromb Haemost; 2015 Nov 25; 114(6):1290-8. PubMed ID: 26446456
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effectiveness and safety of dabigatran and warfarin in real-world US patients with non-valvular atrial fibrillation: a retrospective cohort study.
    Lauffenburger JC, Farley JF, Gehi AK, Rhoney DH, Brookhart MA, Fang G.
    J Am Heart Assoc; 2015 Apr 10; 4(4):. PubMed ID: 25862791
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Sex Differences in Dabigatran Use, Safety, And Effectiveness In a Population-Based Cohort of Patients With Atrial Fibrillation.
    Avgil Tsadok M, Jackevicius CA, Rahme E, Humphries KH, Pilote L.
    Circ Cardiovasc Qual Outcomes; 2015 Nov 10; 8(6):593-9. PubMed ID: 26508666
    [Abstract] [Full Text] [Related]

  • 7. Comparative effectiveness and safety of warfarin and dabigatran in patients with non-valvular atrial fibrillation in Japan: A claims database analysis.
    Koretsune Y, Yamashita T, Yasaka M, Ono Y, Hirakawa T, Ishida K, Kuroki D, Sumida T, Urushihara H.
    J Cardiol; 2019 Mar 10; 73(3):204-209. PubMed ID: 30477926
    [Abstract] [Full Text] [Related]

  • 8. Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation.
    Norby FL, Bengtson LGS, Lutsey PL, Chen LY, MacLehose RF, Chamberlain AM, Rapson I, Alonso A.
    BMC Cardiovasc Disord; 2017 Sep 06; 17(1):238. PubMed ID: 28874129
    [Abstract] [Full Text] [Related]

  • 9. Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation.
    Graham DJ, Reichman ME, Wernecke M, Zhang R, Southworth MR, Levenson M, Sheu TC, Mott K, Goulding MR, Houstoun M, MaCurdy TE, Worrall C, Kelman JA.
    Circulation; 2015 Jan 13; 131(2):157-64. PubMed ID: 25359164
    [Abstract] [Full Text] [Related]

  • 10. Outcomes of Dabigatran and Warfarin for Atrial Fibrillation in Contemporary Practice: A Retrospective Cohort Study.
    Go AS, Singer DE, Toh S, Cheetham TC, Reichman ME, Graham DJ, Southworth MR, Zhang R, Izem R, Goulding MR, Houstoun M, Mott K, Sung SH, Gagne JJ.
    Ann Intern Med; 2017 Dec 19; 167(12):845-854. PubMed ID: 29132153
    [Abstract] [Full Text] [Related]

  • 11. Propensity Score Weighting Compared to Matching in a Study of Dabigatran and Warfarin.
    Seeger JD, Bykov K, Bartels DB, Huybrechts K, Schneeweiss S.
    Drug Saf; 2017 Feb 19; 40(2):169-181. PubMed ID: 27900668
    [Abstract] [Full Text] [Related]

  • 12. Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients.
    Laliberté F, Cloutier M, Nelson WW, Coleman CI, Pilon D, Olson WH, Damaraju CV, Schein JR, Lefebvre P.
    Curr Med Res Opin; 2014 Jul 19; 30(7):1317-25. PubMed ID: 24650301
    [Abstract] [Full Text] [Related]

  • 13. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
    Mantha S, Ansell J.
    Thromb Haemost; 2012 Sep 19; 108(3):476-84. PubMed ID: 22740145
    [Abstract] [Full Text] [Related]

  • 14. Dabigatran use in elderly patients with atrial fibrillation.
    Avgil-Tsadok M, Jackevicius CA, Essebag V, Eisenberg MJ, Rahme E, Behlouli H, Pilote L.
    Thromb Haemost; 2016 Jan 19; 115(1):152-60. PubMed ID: 26354766
    [Abstract] [Full Text] [Related]

  • 15. Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin.
    Zalesak M, Siu K, Francis K, Yu C, Alvrtsyan H, Rao Y, Walker D, Sander S, Miyasato G, Matchar D, Sanchez H.
    Circ Cardiovasc Qual Outcomes; 2013 Sep 01; 6(5):567-74. PubMed ID: 23922182
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of dabigatran etexilate and warfarin in "real-world" patients with atrial fibrillation: a prospective nationwide cohort study.
    Larsen TB, Rasmussen LH, Skjøth F, Due KM, Callréus T, Rosenzweig M, Lip GY.
    J Am Coll Cardiol; 2013 Jun 04; 61(22):2264-73. PubMed ID: 23562920
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [The X-VeRT study].
    Colonna P, Troccoli R, Botto GL.
    G Ital Cardiol (Rome); 2015 Jun 04; 16(6):325-8; discussion 328-30. PubMed ID: 26156692
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.